This measure of functional remyelination after stroke demonstrates reduced peri-infarct MBP+ immunoreactivity at 28 days post-stroke in DIO mice compared with control mice (p < 0.0001, two-way ANOVA, F = 3.11) (Figure 2D), indicating a failure of post-stroke remyelination. The gene discussed is MBP; the disease is Stroke.